<div id=toc></div>

# Table of Contents

- [cs.LG](#cs.LG) [Total: 1]


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [1] [Training Together, Diagnosing Better: Federated Learning for Collagen VI-Related Dystrophies](https://arxiv.org/abs/2512.16876)
*Astrid Brull,Sara Aguti,Véronique Bolduc,Ying Hu,Daniel M. Jimenez-Gutierrez,Enrique Zuazua,Joaquin Del-Rio,Oleksii Sliusarenko,Haiyan Zhou,Francesco Muntoni,Carsten G. Bönnemann,Xabi Uribe-Etxebarria*

Main category: cs.LG

TL;DR: 通过跨机构的联邦学习，使用COL6相关免疫荧光显微图像，在两家国际组织的分布式数据上将COL6-RD三种致病机制分级，F1达到0.82，优于单机构模型。


<details>
  <summary>Details</summary>
Motivation: 解决罕见疾病数据稀缺、碎片化及隐私/合规性挑战，利用联邦学习实现跨机构协作训练，提高诊断可及性、泛化性与临床解释潜力。

Method: 在两家国际机构的分布式数据集上，利用患者来源的成纤维细胞 COLLAGEN VI 免疫荧光显微图像，应用联邦学习在全局平台（Sherpa.ai FL）训练模型，将影像分类为COL6-RD的三大致病机制：外显子跳跃、甘氨酸置换、假外显子插入。

Result: 模型在全局数据上的F1-score为0.82，显著高于单机构模型（0.57–0.75），表明FL提升诊断效用与泛化能力。

Conclusion: 联邦学习可显著提升COL6-RD的诊断准确性和可推广性，并可能辅助解释变异性不明确的变体、优化测序策略以识别新致病变体。

Abstract: The application of Machine Learning (ML) to the diagnosis of rare diseases, such as collagen VI-related dystrophies (COL6-RD), is fundamentally limited by the scarcity and fragmentation of available data. Attempts to expand sampling across hospitals, institutions, or countries with differing regulations face severe privacy, regulatory, and logistical obstacles that are often difficult to overcome. The Federated Learning (FL) provides a promising solution by enabling collaborative model training across decentralized datasets while keeping patient data local and private. Here, we report a novel global FL initiative using the Sherpa.ai FL platform, which leverages FL across distributed datasets in two international organizations for the diagnosis of COL6-RD, using collagen VI immunofluorescence microscopy images from patient-derived fibroblast cultures. Our solution resulted in an ML model capable of classifying collagen VI patient images into the three primary pathogenic mechanism groups associated with COL6-RD: exon skipping, glycine substitution, and pseudoexon insertion. This new approach achieved an F1-score of 0.82, outperforming single-organization models (0.57-0.75). These results demonstrate that FL substantially improves diagnostic utility and generalizability compared to isolated institutional models. Beyond enabling more accurate diagnosis, we anticipate that this approach will support the interpretation of variants of uncertain significance and guide the prioritization of sequencing strategies to identify novel pathogenic variants.

</details>
